Sorbus Advisors LLC

About
Services
Professionals
Resources
Blog
Contact

2015 Goodwill / Intangibles Benchmarking BioPharmaceuticals

December 15, 2016 | by Max Fonarev

Recent Posts

Covid-19 | Valuation Update | Three Months In
COVID-19 | Valuation Update
Valuing VC Investments – An Intuitive Example
Valuation Market Multiples: Not So Simple
Purchase Price Allocation (ASC 805) Benchmarking Study IT 2018

Labels

Intangible Asset Valuation IP Valuation Purchase Accounting Tax Valuation Life Sciences ASC 805 Purchase Accounting Transactions Fair Market Value Tax Compliance Business Interests Fair Value 409A Valuation Financial Instruments Purchase Price Allocation Term Sheet Portfolio Valuation Financial Reporting ASC 805

Twitter
Linkedin

© 2021 Sorbus Advisors LLC. All Rights Reserved. | Terms of Use | Privacy Policy

Please leave your email address below to view this publication. By doing so, you consent to receive our quarterly newsletters. You can unsubscribe at any time.

First Name*
Last Name*
Company
Newsletter Sign up*